ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in biomarker imaging technologies for the early ...

Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a groundbreaking study leveraging samples from the National Lung Screening Trial (NLST).

Jefferies London Healthcare Conference 2025 November 20, 2025 3:00 AM ESTCompany ParticipantsVipin Garg - President, CEO ...

Carotid artery disease restricts blood flow to the brain. Left undiagnosed, plaque buildup may lead to a stroke. Early detection may allow medication or lifestyle changes that lower the risk. A ...

About a year ago, a test revealed that I had an 8-mm stone in my kidney. My kidney doctor was not worried about it. I have ...

The Diagnostic Labs Market is poised for growth due to rising chronic disease prevalence, aging populations, and advancements in technology. Key opportunities include leveraging AI for better data ...

Molecular profiles will give detailed snapshot of person’s physiology and predict diseases from diabetes to cancer and dementia ...

Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved HYRNUO® (sevabertinib), an oral, reversible, tyrosine kinase inhibitor (TKI), for the treatment of adult patients ...

Designed to generate data and outcomes on bone and muscle health in both healthy people and those with disease, a novel ...

Men diagnosed with prostate cancer have traditionally faced two choices: do nothing and hope the tumor doesn’t grow between ...

The process of TIL therapy is complex and requires the coordination of multiple specialties at authorized treatment centers, ...

This study presents a case report on pain management and comfort care practices for a 52-year-old male patient with advanced osteosarcoma recurrence and systemic metastasis. The patient presented with ...